Brooks Laboratories Share Price

Small Cap | Pharmaceuticals and health care | NSE: BROOKS | BSE: 533543

₹101.55 image-0.79 (-0.77 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 103.36

High (₹) 104.50

Low (₹) 100.00

Prev. Close (₹) 102.34

Volume 3,615

VWAP (₹) 99.12

ROCE (%) 3.56

Industry P/E 43.95

TTM P/E -14.55

P/B Ratio 4.07

Market Cap (₹) Cr.299.82

Dividend Yield (%)--

EPS (₹) -7.65

ROE-30.61%

Sales Growth (%) 25.76

Profit Growth (%)-105.51

Day Range

104.50104.50

L
H

52 Week Range

72.51202.80

L
H

Historical Returns

Returns (6M)

-36.49 %

Returns (1Y)

-5.71 %

Returns (3Y)

13.93 %

Returns (5Y)

428.63 %

Returns (6M)

-36.49 %

Returns (1Y)

-5.71 %

Returns (3Y)

13.93 %

Returns (5Y)

428.63 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with Low Debt
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Increasing Revenue every Quarter for the past 4 Quarters
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 41.57

MFI 38.11

ATR 12.59

Commodity Channel Index -141.72

ROC125 -18.64

ROC21 -33.48

Williams %R -99.03

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current104.66110.88114.31101.2395.0191.5885.36
Week Ago127.41132.03134.71124.73120.11117.43112.81
Month Ago155.36156.23156.66154.93154.06153.63152.76

EMA & SMA
info_icon

101.55

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 116.27


9 Day 118.55


10 Day 121.76


12 Day 126.59


14 Day 130.14

20 Day 138.40


26 Day 142.13


50 Day 157.56


100 Day 149.69


200 Day 127.55

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
ATUL RANCHALbulkSell14 Nov, 2024₹137.402,00,000BSE
ARYAN MAHAJANbulkSell14 Nov, 2024₹137.404,80,000BSE
RR FAMILY TRUSTbulkBuy14 Nov, 2024₹137.402,18,300BSE
RAGHAV VIJAY KAROLbulkSell29 Jul, 2021₹89.001,50,000BSE
KHUSHBOO DINESH BUTAILbulkBuy29 Jul, 2021₹89.001,50,000BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
17 Nov, 2024Atul RanchalDisposal₹136.403,95,011BSE
17 Nov, 2024Saras GuptaDisposal₹137.401,15,404BSE
17 Nov, 2024Aryan MahajanDisposal₹137.404,80,000BSE
17 Nov, 2024Atul RanchalDisposal₹137.402,00,000BSE
31 Aug, 2023Selina Ranchal RevisedAcquisition₹75.0046,868BSE
31 Aug, 2023Aryan Mahajan RevisedAcquisition₹75.0070,970BSE
31 Aug, 2023Davinder Kumari RevisedAcquisition₹75.004,698BSE
31 Aug, 2023Davinder KumariAcquisition₹10.004,698BSE
31 Aug, 2023Selina RanchalAcquisition₹10.0046,868BSE
31 Aug, 2023Savvy RanchalAcquisition₹10.0090,952BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
25 Jan, 2023Rights issue of equity shares of Rs. 10/- in the ratio of 1:16 @ premium of Rs. 65/-.28 Jul, 202328 Jul, 2023

Announcements

DateSourceDetail
07 Mar, 2025NSE IndiaThe Exchange had sought clarification from Brooks Laboratories Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. The response of the Company is enclosed.
04 Mar, 2025NSE IndiaThe Exchange has sought clarification from Brooks Laboratories Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. The response of the Company is awaited.
28 Feb, 2025BSE IndiaRevision of Integrated Filing (Financial) for the quarter and nine months ended 31st December 2024.
28 Feb, 2025BSE IndiaRevision of Integrated Filing (Financial) for the quarter and nine months ended 31st December 2024.
28 Feb, 2025NSE IndiaBrooks Laboratories Limited has informed the Exchange about General Updates Integrated Filing (Financial) for the quarter and nine months ended 31st December, 2024 (Revised).
25 Feb, 2025BSE IndiaRevision of the outcome of the Board Meeting held on 13th February 2025.
25 Feb, 2025NSE IndiaBrooks Laboratories Limited has informed the Exchange regarding, revision in outcome of the Board Meeting held on 13th February 2025.
14 Feb, 2025NSE IndiaBrooks Laboratories Limited has informed the Exchange about Copy of Newspaper Publication for Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December 2024.
13 Feb, 2025NSE IndiaIntegrated Filing (Financial) for the quarter and nine months ended December 31, 2024
13 Feb, 2025BSE IndiaIntegrated Filing (Financial) for the quarter and nine months ended 31st December 2024.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--11 Feb, 202513 Feb, 2025
To consider Fund Raising & OthersInter-alia, to consider and approve 1. Proposal for Raising Funds through the issuance of securities (Equity Shares) by way of a preferential issue. 2. To approve the EGM. 3. Other business matters.17 Dec, 202411 Dec, 2024
Quarterly Results--07 Nov, 202409 Nov, 2024
Quarterly Results--07 Aug, 202414 Aug, 2024
Audited Results--14 May, 202418 May, 2024
Quarterly Results--25 Jan, 202431 Jan, 2024
Rights & Preferential issue--19 Jan, 202424 Jan, 2024
Quarterly Results--02 Nov, 202309 Nov, 2023
Quarterly Results--03 Aug, 202310 Aug, 2023
Rights issue of Equity Shares--12 Jul, 202318 Jul, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameJan, 2025Dec, 2024Sept, 2024Jun, 2024Mar, 2024

About Brooks Laboratories

Brooks Laboratories is a Public Limited Listed company incorporated on 23/01/2002 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24232HP2002PLC000267 and registration number is 000267. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 79.49 Cr. and Equity Capital is Rs. 26.25 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

2002

Managing Director

-- --

NSE Symbol

BROOKS

Brooks Laboratories Management

NameDesignation
Ms. Sonia GuptaIndependent Director
Mr. Jitendra Pratap SinghWhole Time Director
Mr. Durga Shankar MaityWhole Time Director
Mr. Bhushan Singh RanaWhole Time Director
Mr. Lalit MahajanAddnl.Independent Director
Dr. Usha SinghAddnl.Independent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Brooks Laboratories

What is the share price of Brooks Laboratories?

The share price of Brooks Laboratories on 13 Mar, 2025 is ₹ 101.55.

What is 52W high and 52W low share price of Brooks Laboratories?

The highest and lowest 52W share prices of Brooks Laboratories are ₹ 202.800 and ₹ 72.510

What is the market cap of Brooks Laboratories?

The market capitalization of Brooks Laboratories as of 13 Mar, 2025 is ₹ 299.82 Crores

What is the P/E ratio of Brooks Laboratories?

The current P/E ratio of Brooks Laboratories as of 13 Mar, 2025 is 43.95

What is the PB ratio of Brooks Laboratories?

The PB ratio of Brooks Laboratories as of 13 Mar, 2025 is 4.07

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited